Steroid withdrawal in pediatric kidney transplant allows better growth, lipids and body composition: a randomized controlled trial.
dc.contributor.author | Mericq, Verónica | |
dc.contributor.author | Salas, Paulina | |
dc.contributor.author | Pinto, Viola | |
dc.contributor.author | Cano, Francisco | |
dc.contributor.author | Reyes, Loreto | |
dc.contributor.author | Brown, Keenan | |
dc.contributor.author | Gonzalez, Magdalena | |
dc.contributor.author | Michea, Luis | |
dc.contributor.author | Delgado, Iris | |
dc.contributor.author | Delucchi, Ángela | |
dc.date.accessioned | 2017-04-06T15:42:13Z | |
dc.date.available | 2017-04-06T15:42:13Z | |
dc.date.issued | 2013 | |
dc.description | Centro de Epidemiología y Políticas de Salud | |
dc.description.abstract | BACKGROUND: Glucocorticoid immunosuppressant therapy in pediatric kidney transplant (Tx) recipients does not allow the improvement of growth after Tx. OBJECTIVE: To determine the effect of early steroid withdrawal (SW) on longitudinal growth, insulin sensitivity (IS), and body composition (BC). METHODS: This was a prospective, randomized, multicenter study in Tx. Insulin-like growth factor (IGF)-I, IGF-binding protein 3 (IGFBP3), IS, and BC (DEXA/pQCT) were determined at baseline and up to 12 months after Tx. RESULTS: A total of 30 patients were examined; 14 patients were assigned to the SW group (7 male, 7 female; 12 in Tanner stage I) and 16 patients were assigned to the steroid control (SC) group (10 male, 6 female;12 in Tanner stage I). Their chronological age was 7.8 ± 4.3 years, height was -2.3 ± 0.99 SD scores (SDS), and body mass index -0.3 ± 1.2 SDS. After 1 year, the SW group showed an increase in height SDS (+1.2 ± 0.22 vs. +0.60 ± 0.13 SDS in the SC group, p < 0.02), lower IGFBP3 (p < 0.05), cholesterol (p < 0.05), and higher high-density lipoprotein cholesterol (p < 0.05). SW patients had lower trunk fat with no differences in IS. Only in prepubertal patients, the SW group had lower glycemia (p < 0.05), very low-density lipoprotein cholesterol (p < 0.01), triglycerides (p < 0.05), triglycerides/glycemia index (TyG; p < 0.02), and better lean mass. Both groups showed an improvement in lean mass after kidney Tx. CONCLUSIONS: SW improved longitudinal growth, lipid profile, and trunk and lean fat in Tx patients. In prepubertal recipients, the decrease in TyG suggests better IS. | |
dc.format.extent | 1 | |
dc.identifier.citation | Horm Res Paediatr. 2013;79(2):88-96 | |
dc.identifier.uri | http://hdl.handle.net/11447/1100 | |
dc.identifier.uri | http://dx.doi.org/10.1159/000347024 | |
dc.language.iso | en_US | |
dc.publisher | Karger | |
dc.subject | Adiposity | |
dc.subject | Body Height | |
dc.subject | Body Mass Index | |
dc.subject | Cholesterol/blood | |
dc.subject | Immunosuppressive Agents | |
dc.subject | Kidney Transplantation | |
dc.subject | Steroids | |
dc.title | Steroid withdrawal in pediatric kidney transplant allows better growth, lipids and body composition: a randomized controlled trial. | |
dc.type | Artículo |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Steroid withdrawal in pediatric kidney transplant allows better growth lipids and body composition a randomized controlled trial___resumen.pdf
- Size:
- 183.96 KB
- Format:
- Adobe Portable Document Format
- Description:
- Resumen